CAS 171440-18-9
:2-[(R)-{[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl}sulfinyl]-1H-benzimidazole-sodium (1:1)
Description:
The chemical substance known as "2-[(R)-{[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl}sulfinyl]-1H-benzimidazole-sodium (1:1)" with CAS number 171440-18-9 is a sodium salt of a benzimidazole derivative. This compound features a complex structure that includes a benzimidazole core, which is known for its diverse biological activities, and a sulfinyl group that may enhance its pharmacological properties. The presence of a pyridine ring and a methoxypropoxy substituent suggests potential interactions with biological targets, possibly influencing its solubility and bioavailability. The (R)-configuration indicates chirality, which can significantly affect the compound's activity and interaction with biological systems. As a sodium salt, it is likely to exhibit improved solubility in aqueous environments, making it suitable for various applications, including pharmaceuticals. Overall, this compound's unique structural features may contribute to its potential therapeutic effects, although specific biological activities would require further investigation.
Formula:C18H21N3NaO3S
Synonyms:- 1H-Benzimidazole, 2-[(R)-[(1R)-[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-, sodium salt (1:1)
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
(R)-(+)-Rabeprazole sodium
CAS:Formula:C18H20N3NaO3SPurity:95%Color and Shape:SolidMolecular weight:381.4245(R)-Rabeprazole Sodium Salt
CAS:Formula:C18H20N3O3S·NaColor and Shape:Pale Yellow SolidMolecular weight:358.44 22.99(R)-Rabeprazole Sodium Salt
CAS:Controlled Product<p>Applications A partially reversible gastric proton pump inhibitor.<br>References Moda, T., et al.: Lett. Drug Des. Discov., 4, 502 (2007), Belaz, K., et al.: J. Pharm. Biomed. Anal., 47, 81 (2008),<br></p>Formula:C18H20N3NaO3SColor and Shape:NeatMolecular weight:381.42(R)-Rabeprazole sodium
CAS:<p>Rabeprazole sodium is a proton pump inhibitor that inhibits gastric acid secretion by blocking the final step of acid production. Rabeprazole sodium is a white to off-white crystalline powder with a molecular weight of 579.87 and a melting point of 137-138°C. It has an acetate extraction process, which involves the conversion of alcohols to their corresponding salts, followed by precipitation with acetic acid. The synthetic process for rabeprazole sodium involves the reaction of maleic anhydride and protonated benzene or phenol. The powder diffraction spectrum for this molecule exhibits peaks at 2θ = 6.6°, 7.7°, 8.8°, 12.2°, 15.1°, 16.9°, 18° and 19°. Maleic anhydride is used as a starting material in the synthesis process and can be synthesized from ethylene glycol and phthalic anhydride</p>Formula:C18H20N3NaO3SPurity:Min. 95%Color and Shape:PowderMolecular weight:381.42 g/mol






